Search

Why the traditional model of drug development is no longer fit for purpose.

Michael Altorfer, CEO, Swiss Biotech Association, gives his view on the future of drug development.

Sitting Down With… Lars Petersen, President and CEO, FUJIFILM Diosynth Biotechnologies

Digital twins in clinical trials are changing how research is performed – but it won’t be a revolution, according to Phesi CEO Gen Li.

We interview Lars Erwig, Director of the Centre of Drug Development at Cancer Research UK, about his career.

What’s going on with nitrosamines? Naiffer Romero from the USP walks us through frequently asked questions.

The search for an effective treatment for childhood brain cancers goes on, but a modified Herpes virus could represent a breakthrough.

Drug shortages are everywhere. We speak with Vimala Raghavendran at the US Pharmacopeia to get the full picture.

If used correctly, AI and ML expand our knowledge of biology and vastly improve the speed of success in the clinic.

We get the background on a new manufacturing platform for cell and gene therapy from Ori Biotech, tested by MD Anderson and Resilience’s CTMC.